CH CRL (R4)
0.9.0 - Draft
CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nkrs-variables"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">3.6.2<a name="nkrs-variables-3.466.462"> </a></td><td>Associated in situ tumour</td></tr><tr><td style="white-space:nowrap">3.9.1<a name="nkrs-variables-3.469.461"> </a></td><td>ICCC-3 main group</td></tr><tr><td style="white-space:nowrap">3.9.2<a name="nkrs-variables-3.469.462"> </a></td><td>ICCC-3 code</td></tr><tr><td style="white-space:nowrap">3.9.3<a name="nkrs-variables-3.469.463"> </a></td><td>ICCC-3 extended code</td></tr><tr><td style="white-space:nowrap">4.19<a name="nkrs-variables-4.4619"> </a></td><td>COG staging</td></tr><tr><td style="white-space:nowrap">4.20<a name="nkrs-variables-4.4620"> </a></td><td>COG ALL staging</td></tr><tr><td style="white-space:nowrap">4.21<a name="nkrs-variables-4.4621"> </a></td><td>FIGO staging</td></tr><tr><td style="white-space:nowrap">4.22<a name="nkrs-variables-4.4622"> </a></td><td>INRGSS staging</td></tr><tr><td style="white-space:nowrap">4.23<a name="nkrs-variables-4.4623"> </a></td><td>IRSS staging</td></tr><tr><td style="white-space:nowrap">4.24<a name="nkrs-variables-4.4624"> </a></td><td>Lugano staging</td></tr><tr><td style="white-space:nowrap">4.25<a name="nkrs-variables-4.4625"> </a></td><td>PRETEXT staging</td></tr><tr><td style="white-space:nowrap">4.28<a name="nkrs-variables-4.4628"> </a></td><td>Rhabdomyosarcoma site staging</td></tr><tr><td style="white-space:nowrap">4.30<a name="nkrs-variables-4.4630"> </a></td><td>DSSplus</td></tr><tr><td style="white-space:nowrap">4.31<a name="nkrs-variables-4.4631"> </a></td><td>SIOP staging</td></tr><tr><td style="white-space:nowrap">4.32<a name="nkrs-variables-4.4632"> </a></td><td>St. Jude / Murphy staging</td></tr><tr><td style="white-space:nowrap">4.33.2<a name="nkrs-variables-4.4633.462"> </a></td><td>Toronto Tier II (manual) staging</td></tr><tr><td style="white-space:nowrap">4.34<a name="nkrs-variables-4.4634"> </a></td><td>Creasman grading system</td></tr><tr><td style="white-space:nowrap">4.35<a name="nkrs-variables-4.4635"> </a></td><td>Elston/Ellis grading system</td></tr><tr><td style="white-space:nowrap">4.36<a name="nkrs-variables-4.4636"> </a></td><td>SalzerKuntschik grading system</td></tr><tr><td style="white-space:nowrap">4.37<a name="nkrs-variables-4.4637"> </a></td><td>Shimada grading system</td></tr><tr><td style="white-space:nowrap">4.38<a name="nkrs-variables-4.4638"> </a></td><td>WHO(CNS) grading system</td></tr><tr><td style="white-space:nowrap">4.39<a name="nkrs-variables-4.4639"> </a></td><td>Clinical tumour size</td></tr><tr><td style="white-space:nowrap">4.40<a name="nkrs-variables-4.4640"> </a></td><td>Pathological tumour size</td></tr><tr><td style="white-space:nowrap">6.1<a name="nkrs-variables-6.461"> </a></td><td>Residual invasive tumour</td></tr><tr><td style="white-space:nowrap">6.2<a name="nkrs-variables-6.462"> </a></td><td>Residual in-situ tumour</td></tr><tr><td style="white-space:nowrap">6.3<a name="nkrs-variables-6.463"> </a></td><td>Resection margin invasive tumour</td></tr><tr><td style="white-space:nowrap">6.4<a name="nkrs-variables-6.464"> </a></td><td>Resection margin in-situ tumour</td></tr><tr><td style="white-space:nowrap">8.4<a name="nkrs-variables-8.464"> </a></td><td>Morphology term before change of main diagnosis</td></tr><tr><td style="white-space:nowrap">8.5<a name="nkrs-variables-8.465"> </a></td><td>Morphology term after Transformation</td></tr><tr><td style="white-space:nowrap">8.6<a name="nkrs-variables-8.466"> </a></td><td>Topography(s) of post-diagnosis metastases</td></tr><tr><td style="white-space:nowrap">10.3<a name="nkrs-variables-10.463"> </a></td><td>HIV/AIDS</td></tr><tr><td style="white-space:nowrap">10.9<a name="nkrs-variables-10.469"> </a></td><td>Cerebrovascular Accident or Transient Ischemic Attack</td></tr><tr><td style="white-space:nowrap">10.11<a name="nkrs-variables-10.4611"> </a></td><td>Hemiplegia / Paraplegia</td></tr><tr><td style="white-space:nowrap">10.12<a name="nkrs-variables-10.4612"> </a></td><td>Connective Tissue Disease - Rheumatic disease</td></tr></table></div>
</text>
<url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-variables"/>
<version value="0.9.0"/>
<name value="NkrsVariables"/>
<title value="NKRS Variables"/>
<status value="active"/>
<date value="2022-02-04T14:14:21+01:00"/>
<publisher value="Bundesamt für Gesundheit BAG"/>
<contact>
<name value="Bundesamt für Gesundheit BAG"/>
<telecom>
<system value="url"/>
<value value="https://www.bag.admin.ch/"/>
</telecom>
</contact>
<description
value="NKRS codes for data elements for which there is no international code (e.g. LOINC or SNOMED CT)
that accurately describes the meaning of the NKRS variable. This code system is based on
\'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))
and
\'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/b1-datadictionary-supplementaryvariables-adults-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/variablen-zusatzdaten-kinderjugendliche-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/b1-dict-des-donnees-variables-suppl-adultes-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/b1-variabili-supplementari-adulti-v1.1.pdf))."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC-BY-SA-4.0"/>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="34"/>
<concept>
<code value="3.6.2"/>
<display value="Associated in situ tumour"/>
</concept>
<concept>
<code value="3.9.1"/>
<display value="ICCC-3 main group"/>
</concept>
<concept>
<code value="3.9.2"/>
<display value="ICCC-3 code"/>
</concept>
<concept>
<code value="3.9.3"/>
<display value="ICCC-3 extended code"/>
</concept>
<concept>
<code value="4.19"/>
<display value="COG staging"/>
</concept>
<concept>
<code value="4.20"/>
<display value="COG ALL staging"/>
</concept>
<concept>
<code value="4.21"/>
<display value="FIGO staging"/>
</concept>
<concept>
<code value="4.22"/>
<display value="INRGSS staging"/>
</concept>
<concept>
<code value="4.23"/>
<display value="IRSS staging"/>
</concept>
<concept>
<code value="4.24"/>
<display value="Lugano staging"/>
</concept>
<concept>
<code value="4.25"/>
<display value="PRETEXT staging"/>
</concept>
<concept>
<code value="4.28"/>
<display value="Rhabdomyosarcoma site staging"/>
</concept>
<concept>
<code value="4.30"/>
<display value="DSSplus"/>
</concept>
<concept>
<code value="4.31"/>
<display value="SIOP staging"/>
</concept>
<concept>
<code value="4.32"/>
<display value="St. Jude / Murphy staging"/>
</concept>
<concept>
<code value="4.33.2"/>
<display value="Toronto Tier II (manual) staging"/>
</concept>
<concept>
<code value="4.34"/>
<display value="Creasman grading system"/>
</concept>
<concept>
<code value="4.35"/>
<display value="Elston/Ellis grading system"/>
</concept>
<concept>
<code value="4.36"/>
<display value="SalzerKuntschik grading system"/>
</concept>
<concept>
<code value="4.37"/>
<display value="Shimada grading system"/>
</concept>
<concept>
<code value="4.38"/>
<display value="WHO(CNS) grading system"/>
</concept>
<concept>
<code value="4.39"/>
<display value="Clinical tumour size"/>
</concept>
<concept>
<code value="4.40"/>
<display value="Pathological tumour size"/>
</concept>
<concept>
<code value="6.1"/>
<display value="Residual invasive tumour"/>
</concept>
<concept>
<code value="6.2"/>
<display value="Residual in-situ tumour"/>
</concept>
<concept>
<code value="6.3"/>
<display value="Resection margin invasive tumour"/>
</concept>
<concept>
<code value="6.4"/>
<display value="Resection margin in-situ tumour"/>
</concept>
<concept>
<code value="8.4"/>
<display value="Morphology term before change of main diagnosis"/>
</concept>
<concept>
<code value="8.5"/>
<display value="Morphology term after Transformation"/>
</concept>
<concept>
<code value="8.6"/>
<display value="Topography(s) of post-diagnosis metastases"/>
</concept>
<concept>
<code value="10.3"/>
<display value="HIV/AIDS"/>
</concept>
<concept>
<code value="10.9"/>
<display value="Cerebrovascular Accident or Transient Ischemic Attack"/>
</concept>
<concept>
<code value="10.11"/>
<display value="Hemiplegia / Paraplegia"/>
</concept>
<concept>
<code value="10.12"/>
<display value="Connective Tissue Disease - Rheumatic disease"/>
</concept>
</CodeSystem>